Keren Leshem
CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
OCON Therapeutics
Former names: Ocon Medical
Spherical Intrauterine Drug Delivery Platform
Stealth Mode
Apr 2026 ceased to operate
OCON Therapeutics
OCON Therapeutics Overview
OCON Therapeutics innovates, develops, manufactures, and commercializes women's health products based on its proprietary and patented intrauterine ball (IUB) platform. Made from the super-elastic alloy nitinol, the IUB is an ideal carrier of multiple drugs to the uterus for treating a variety of conditions.
In addition to its flagship product, the IUB Ballerine, OCON Therapeutics is developing a pipeline of products utilizing the IUB frame for indications including abnormal uterine bleeding, heavy menstrual bleeding, myomas and fibroids, and infertility.
In addition to its flagship product, the IUB Ballerine, OCON Therapeutics is developing a pipeline of products utilizing the IUB frame for indications including abnormal uterine bleeding, heavy menstrual bleeding, myomas and fibroids, and infertility.
Cumulative Funding Raised Over Time ($)
Employees Over Time
OCON Therapeutics Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Jul 16, 2024
www.calcalistech.com
OCON Therapeutics raises $10 million for innovative IUD and women’s health solutions | CTech
#Investment #Expand
Jun 24, 2024
www.finsmes.com
OCON Therapeutics Raises $10M in Funding
#Investment
Jul 2, 2023
www.calcalistech.com
OCON Therapeutics improving women's quality of life with innovative IUD design and targeted health solutions | CTech
#Customers #Investment
Jun 27, 2022
www.prnewswire.com
Significant breakthrough: The FEMTECH company OCON Healthcare of the Merchavia Investments Group has signed an exclusive agreement with BioGenuine to market its products in China and Southeast Asian countries
#Partners
Jun 12, 2022
www.themarker.com
האם התקן תוך רחמי בצורת כדור ישנה את האופן שבו מטפלים בנשים?
#Investment, Expand
Companies you might be interested in
Driven by Finder AI
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
AA
PH
DS
DS
AL
Contact Team
Affiliated Organizations
(null)Web & social links
Locations
Israel
HaMiktsoot Blvd 14, Modi'in-Maccabim-Re'ut, Israel
Offices Abroad
Herostrasse 12, 8048 Zrich, Switzerland
Photos & videos
(3)No Data, yet.
Sorry, no content found under this section.
OCON Therapeutics Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)OCON Therapeutics Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
A Round
$4.5M
Dec 2020
5
Investors
$4.5M
Undisclosed Round
$2M
Jun 2020
2
Investors
$2M
Non-Equity Funding
Mergers and Acquisitions
OCON Therapeutics Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Closing Event
Apr 2026
A Round
$4.5M
Dec 2020
5
Investors
$4.5M
Undisclosed Round
$2M
Jun 2020
2
Investors
$2M
OCON Therapeutics News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Jul 16, 2024
www.calcalistech.com
OCON Therapeutics raises $10 million for innovative IUD and women’s health solutions | CTech
#Investment #Expand
Jun 24, 2024
www.finsmes.com
OCON Therapeutics Raises $10M in Funding
#Investment
Jul 2, 2023
www.calcalistech.com
OCON Therapeutics improving women's quality of life with innovative IUD design and targeted health solutions | CTech
#Customers #Investment
Jun 27, 2022
www.prnewswire.com
Significant breakthrough: The FEMTECH company OCON Healthcare of the Merchavia Investments Group has signed an exclusive agreement with BioGenuine to market its products in China and Southeast Asian countries
#Partners
Jun 12, 2022
www.themarker.com
האם התקן תוך רחמי בצורת כדור ישנה את האופן שבו מטפלים בנשים?
#Investment, Expand
OCON Therapeutics Team
No Data, yet.
Sorry, no content found under this section.
AA
Amir Avraham
CFO & GM
PH
Prof. Sergio Haimovich
CMO
DS
Daniela Schardinger
VP Marketing & Medical Affairs
DS
Daniel Sclar
VP OPERATIONS
AL
Adely Levy
VP RA/QA
AL
Adely Levy
VP RA/QA
SB
Shani Ben Hur
Medical Affairs Director
RS
Rachel Safra-Zafrany
DIRECTOR CLINICAL OPERATIONS
RS
Rachel Safra-Zafrany
DIRECTOR CLINICAL OPERATIONS
GL
Galit Levin
DIRECTOR OF CMC
SM
Susanne Mair
International Sales
SA
Susan Alpert
SENIOR REGULATORY ADVISOR
Employees Over Time
Companies you might be interested in
Driven by Finder AI
OCON Therapeutics Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,